GSTM3 (glutathione S-transferase mu 3)

2003-06-01  

Identity

HGNC
LOCATION
1p13.3
LOCUSID
ALIAS
GST5,GSTB,GSTM3-3,GTM3
FUSION GENES

Other Information

Locus ID:

NCBI: 2947
MIM: 138390
HGNC: 4635
Ensembl: ENSG00000134202

Variants:

dbSNP: 2947
ClinVar: 2947
TCGA: ENSG00000134202
COSMIC: GSTM3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000134202ENST00000256594P21266
ENSG00000134202ENST00000256594Q6FGJ9
ENSG00000134202ENST00000361066P21266
ENSG00000134202ENST00000361066Q6FGJ9
ENSG00000134202ENST00000540225A0A0A0MTN3

Expression (GTEx)

0
50
100
150
200
250
300

Pathways

PathwaySourceExternal ID
Glutathione metabolismKEGGko00480
Metabolism of xenobiotics by cytochrome P450KEGGko00980
Drug metabolism - cytochrome P450KEGGko00982
Glutathione metabolismKEGGhsa00480
Metabolism of xenobiotics by cytochrome P450KEGGhsa00980
Drug metabolism - cytochrome P450KEGGhsa00982
Chemical carcinogenesisKEGGhsa05204
Chemical carcinogenesisKEGGko05204
MetabolismREACTOMER-HSA-1430728
Biological oxidationsREACTOMER-HSA-211859
Phase II conjugationREACTOMER-HSA-156580
Glutathione conjugationREACTOMER-HSA-156590
Platinum drug resistanceKEGGko01524
Platinum drug resistanceKEGGhsa01524
Fluid shear stress and atherosclerosisKEGGko05418
Fluid shear stress and atherosclerosisKEGGhsa05418

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA443340AnemiaDiseaseVariantAnnotationassociatedPKPD19786980
PA443937Drug ToxicityDiseaseClinicalAnnotation, VariantAnnotationambiguousPD19786980, 22188361
PA445204Ovarian NeoplasmsDiseaseClinicalAnnotation, VariantAnnotationambiguousPKPD19786980, 22188361
PA445301Peripheral Nervous System DiseasesDiseaseVariantAnnotationassociatedPKPD19786980
PA445846ThrombocytopeniaDiseaseVariantAnnotationassociatedPKPD19786980
PA449014cisplatinChemicalClinicalAnnotation, VariantAnnotationambiguousPKPD19786980, 22188361
PA449165cyclophosphamideChemicalClinicalAnnotation, VariantAnnotationambiguousPKPD19786980, 22188361
PA450688olanzapineChemicalClinicalAnnotation, VariantAnnotationassociatedPK23559402

References

Pubmed IDYearTitleCitations
382287152024GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.0
382287152024GSTM3 enhances radiosensitivity of nasopharyngeal carcinoma by promoting radiation-induced ferroptosis through USP14/FASN axis and GPX4.0
331219822021Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers.6
334828592021Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma.2
342092542021Glutathione S-Transferase M3 Is Associated with Glycolysis in Intrinsic Temozolomide-Resistant Glioblastoma Multiforme Cells.11
331219822021Whole-proteome analysis of mesonephric-derived cancers describes new potential biomarkers.6
334828592021Low GSTM3 expression is associated with poor disease-free survival in resected esophageal squamous cell carcinoma.2
342092542021Glutathione S-Transferase M3 Is Associated with Glycolysis in Intrinsic Temozolomide-Resistant Glioblastoma Multiforme Cells.11
326456152020GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.10
326456152020GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death.10
311723542019LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.31
311723542019LncRNA GAS5 regulates the proliferation, migration, invasion and apoptosis of brain glioma cells through targeting GSTM3 expression. The effect of LncRNA GAS5 on glioma cells.31
295693872018A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.5
300548302018Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.9
295693872018A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.5

Citation

Dessen P

GSTM3 (glutathione S-transferase mu 3)

Atlas Genet Cytogenet Oncol Haematol. 2003-06-01

Online version: http://atlasgeneticsoncology.org/gene/40770/gstm3-(glutathione-s-transferase-mu-3)